INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Oral yeast-derived beta-(1,3) glucan increased salivary lysozyme, CRP, and calprotectin in children with chronic respiratory problems.

Researchers evaluated the effects of 30-day oral administration of 100 mg/day of glucan in 60 children aged 8-12 years with chronic respiratory problems. Salivary levels of albumin, lysozyme, CRP, and calprotectin were measured. The treatment resulted in a significant increase in the production of lysozyme, CRP, and calprotectin.

Study type
Clinical trial
Who was studied
60 children ages 8-12 years with chronic respiratory problems
What was measured
Salivary levels of albumin, lysozyme, C-reactive protein (CRP), and calprotectin

THE PAPER

Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity.

Richter J, Svozil V, Král V, Rajnohová Dobiášová L, Stiborová I, Vetvicka V. Ann Transl Med, 2014.

PubMed 25332991 ↗DOI 10.3978/j.issn.2305-5839.2014.02.01 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.